Literature DB >> 15371587

EGFR mutations and sensitivity to gefitinib.

Steven M Sorscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15371587     DOI： 10.1056/NEJM200409163511221

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.

Authors:  Xian-qiang Sun; Lei Chen; Yao-zong Li; Wei-hua Li; Gui-xia Liu; Yao-quan Tu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

2.  Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors.

Authors:  Eleanor Gutteridge; John F R Robertson
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.